J&J, NewLink Genetics Fast-Track Ebola Vaccine Trials

Drug Industry Daily
A A
Johnson & Johnson and NewLink Genetics are the latest companies to seek Ebola treatments through accelerated human trials of vaccine candidates, an effort that is getting a boost from a collaboration of international regulatory agencies.

To View This Article:

Login

Subscribe To Drug Industry Daily